NCT05752903View on ClinicalTrials.gov

Dexmedetomidine-Propofol Versus Ketamine-Propofol for Sedation of CT Guided Bone Biopsy

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 4, 2023

Primary Completion Date

September 10, 2023

Study Completion Date

September 15, 2023

Conditions
Sedation
Interventions
DRUG

Dexmedetomidine-propofol

1 microgram/kg dexmedetomidine+2.5 mg/kg propofol intravenous (IV) bolus, 0.5 microgram g/kg/h dexmedetomidine+2.5 mg/kg/h propofol infusion

DRUG

Ketamine-Propofol

1 mg/kg ketamine+2.5 mg/kg propofol iv bolus, 0.25 mg/kg/h ketamine+2.5mg/kg/h propofol infusion

Trial Locations (1)

11769

National cancer institute, Cairo

All Listed Sponsors
lead

National Cancer Institute, Egypt

OTHER